A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in ICU

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorEmre Şenocak

About this trial

As part of this study, an intervention program aimed at preventing delirium in patients with subarachnoid hemorrhage treated in the intensive care unit will be implemented. Routine medical treatments, environmental adjustments, and a video-based communication program will be implemented to prevent delirium. In addition, basic body awareness training will be administered.

Patients will be divided into two groups. One group will receive only the routine treatment program recommended by international guidelines (medical, enviromental adjustment and face-to-face interview etc.), while the other group will receive body awareness therapy addition to routine interventions.

Eligibility criteria

Qualifiers

Aged 18-85,

Patients scheduled for intensive care for at least 15 days due to SAH, unruptured intracranial aneurysm, and/or Arterovenous Malformation,

Those with a Mini Mental State Examination score of > 24,

Those with a Glasgow Coma Score of 15,

Disqualifiers

Patients whose GCS fell to 14 or below for any reason during the study period;

Patients who developed septic shock and MODS;

Patients requiring endotrachial intubation and mechanical ventilation due to ARDS;

Those requiring vasopressors such as NE at a rate of >0.25 mcg/kg/min;

Trial design

Treatments tested in this trial

  • Routine Therapy (Medical, environmental accodamation, face-to-face commucation)
  • Biopsychosocial-Based Multimodal Approach

Treatment groups

34 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Emre Şenocak

Lead sponsor

Karadeniz Technical University

Sponsor institution